Figure 1From: A randomized, double-blind comparison of OROS®hydromorphone and controlled-release morphine for the control of chronic cancer pain Study design. BID, twice daily; CR, controlled-release; IR, immediate-release; QD, once-daily; q4h, every 4 hours.Back to article page